Clinical Trial Update: Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Avastin (bevacizumab) in combination with docetaxel in ovarian, fallopian tube, and primary peritoneal cancers has completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-10-11